Clinical Trial Update: Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pembrolizumab in combination with all-trans retinoic acid in advanced melanoma has completed, with results posted in March…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Stage IV Melanoma, Stage III Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-02